Biogen
BIIB
222.15
-0.74
-0.33%
Biogen
US · BIIB
#623 by market cap
Listed 1970
222.15
-0.74
-0.33%
Live - 5344 symbols - heartbeat 486s ago
· 2026-10-08 04:46
Pre-market
222.80
+0.29%
After-hours
222.15
0.00%
Overnight
221.74
-0.18%
- Market cap
- 32.82B
- P/E (TTM)i
- 39.46
- P/Bi
- 1.74
- EPSi
- 8.79
- Div yieldi
- 0.00%
- 52W posi
- 91%
Reader sentiment
Are you bullish or bearish on BIIB?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 26 analysts
Buy
Avg price target
239.95 +8.0%
Price target rangecurrent 222.15
Low175.00
Avg239.95
High300.00
Buy 65%
Hold 31%
Sell 4%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-25 | Bernstein | -- | BUY | 236.00 |
| 2026-09-18 | Wells Fargo | -- | BUY | 250.00 |
| 2026-09-10 | HSBC | -- | SELL | 175.00 |
| 2026-09-09 | BMO Capital | -- | HOLD | -- |
| 2026-09-03 | Piper Sandler | -- | BUY | 245.00 |
| 2026-08-25 | RBC Capital | -- | BUY | 260.00 |
| 2026-08-13 | Wolfe Research | -- | BUY | 300.00 |
| 2026-08-03 | Mizuho Securities | -- | BUY | 241.00 |
| 2026-08-03 | Citi | -- | HOLD | 215.00 |
| 2026-08-02 | Stifel | -- | BUY | 242.00 |
| 2026-07-31 | Truist Financial | -- | BUY | 235.00 |
| 2026-07-31 | Wedbush | -- | HOLD | 215.00 |
| 2026-07-30 | TD Cowen | -- | BUY | 225.00 |
| 2026-07-30 | CCORF | -- | BUY | 248.00 |
| 2026-07-30 | Wells Fargo | -- | BUY | 250.00 |
| 2026-07-30 | UBS | -- | BUY | 240.00 |
| 2026-07-30 | Truist Financial | -- | BUY | -- |
| 2026-07-30 | Wedbush | -- | HOLD | 215.00 |
| 2026-07-30 | Morgan Stanley | -- | HOLD | 231.00 |
| 2026-07-30 | Jefferies | -- | BUY | 255.00 |
| 2026-07-30 | H.C. Wainwright | -- | BUY | 251.00 |
| 2026-07-30 | J.P. Morgan | -- | HOLD | 210.00 |
| 2026-07-29 | TD Cowen | -- | BUY | 225.00 |
| 2026-07-29 | William Blair | -- | BUY | -- |
| 2026-07-29 | BofA Securities | -- | HOLD | 219.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C
Momentum strategy signal
Buy
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Improving
5
■ Upgrades■ Downgrades
- 5 upgrades vs 0 downgrades among tracked analyst rating changes.
- Most recent: Bernstein moved from Hold to Buy on 2026-09-25.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-25 | Bernstein | HOLD → BUY | 236.00 |
| 2026-07-13 | Truist Financial | HOLD → BUY | 235.00 |
| 2026-06-08 | Needham | HOLD → BUY | 255.00 |
| 2026-04-22 | UBS | HOLD → BUY | 225.00 |
| 2026-04-20 | Wells Fargo | HOLD → BUY | 250.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-29 | -- | ±4.37% | +1.76% (in line) |
| 2026/Q1 | 2026-04-29 | -- | ±4.18% | +6.00% (beat) |
| 2025/Q4 | 2026-02-06 | -- | ±5.31% | +8.53% (beat) |
| 2025/Q3 | 2025-10-30 | -- | ±5.42% | +1.18% (in line) |
| 2025/Q2 | 2025-07-31 | -- | ±4.62% | +1.07% (in line) |
| 2025/Q1 | 2025-05-01 | -- | ±5.74% | -0.12% (in line) |
| 2024/Q4 | 2025-02-12 | -- | ±5.69% | -4.28% (in line) |
| 2024/Q3 | 2024-10-30 | -- | ±5.79% | -1.25% (in line) |
| 2024/Q2 | 2024-08-01 | -- | ±6.11% | -1.17% (in line) |
| 2024/Q1 | 2024-04-24 | -- | ±5.85% | +4.56% (in line) |
| 2023/Q4 | 2024-02-13 | -- | ±5.43% | -7.39% (beat) |
| 2023/Q3 | 2023-11-08 | -- | ±5.21% | -5.67% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 04:46:37 · For reference only, not investment advice and not tailored to your situation.